SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Technology Officer of Guardant Health sold $567,132 worth of company stock, a transaction that is not material in the context of the company's multi-billion dollar market capitalization.
• Market Impact: The transaction is too small relative to the company's size to have a meaningful impact on the stock.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Chudova Darya
CIK	0001977179
Title/Position	Chief Technology Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	5,451
Price Per Share	$104.0418
Total Value	$567,131.95
Shares Owned After	7,012
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$567,131.95
% of Market Cap	0.0046%
Shares Transacted	5,451
% of Shares Outstanding	Not Available
Post-Transaction Ownership	7,012 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $12.26 billion, this transaction of approximately $567k represents a negligible fraction (0.0046%) of the company's total value. Such sales are common for executives for personal financial planning and do not typically signal a change in company outlook.
• Ownership Concentration: While the sale reduced the insider's direct holdings by a notable 43.7%, her remaining stake of 7,012 shares indicates continued alignment with shareholder interests. The overall impact on insider ownership concentration is minimal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction size is insignificant compared to Guardant Health's market capitalization and daily trading volume. It is unlikely to influence investor sentiment or stock price.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is too small to affect trading volume patterns.
• Sentiment Indicator: Neutral. This is a routine insider sale that does not carry a strong bullish or bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: The sale was executed at a weighted average price of $104.0418, with prices ranging from $104.0401 to $104.0900. No 10b5-1 plan was indicated in the filing.